Tech Company Financing Transactions
Akura Medical Funding Round
Akura Medical closed a $35 million Series B investment round on 10/3/2023. Investors included Cormorant Asset Management, The Capital Partnership and AMED Ventures.
Transaction Overview
Company Name
Announced On
10/3/2023
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors
Cormorant Asset Management (Lead Investor)
The Capital Partnership (Lead Investor)
Proceeds Purpose
The company intends to use the funds to apply for FDA 510(k) clearance for the Akura Mechanical Thrombectomy Platform, support clinical trials for additional indications, and scale manufacturing capabilities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
170 Knowles Drive
Los Gatos, CA 95032
USA
Los Gatos, CA 95032
USA
Phone
Website
Email Address
Overview
Focused on providing effective and easy-to-use clot removal to efficiently treat venous thromboembolisms (VTE).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Murali Srivathsa
Chief Financial Officer
David Voris
Co-Founder
Aadel Al-Jadda
Co-Founder
Amr Salahieh
VP - Operations
Eric Lang
Browse more venture capital transactions:
Prev: 10/3/2023: Pulumi venture capital transaction
Next: 10/3/2023: Granular SAS venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs